Vimarsana
Biggest News Aggregation in the World

Page 12 - Dan Cooper News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dan Cooper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dan Cooper Today - Breaking & Trending Today

More teens are turning to weight loss drugs - Vimarsana News

More teens are turning to weight loss drugs

Thousands of prescriptions of semaglutide, sold under the brand names Wegovy and Ozempic, were written for children ages 12 to 17 in 2023, according to PurpleLab data.

Source: yahoo.com
More teens are turning to weight loss drugs, though some experts push back - Vimarsana News

More teens are turning to weight loss drugs, though some experts push back

Thousands of prescriptions of semaglutide, sold under the brand names Wegovy and Ozempic, were written for children ages 12 to 17 in 2023, according to PurpleLab data.

Source: aol.com
Nearly 4,000 weight loss drug prescriptions in 2023 were for US teens - Vimarsana News

Nearly 4,000 weight loss drug prescriptions in 2023 were for US teens

A growing trend of prescribing weight loss drugs like Wegovy and Ozempic to children in the US is concerning some physicians.

Mortgage demand will 'rebound' in 2024: EY ITEM Club  – Mortgage Strategy - Vimarsana News

Mortgage demand will 'rebound' in 2024: EY ITEM Club  – Mortgage Strategy

Demand for home loans is expected to “rebound this year, buoyed by the prospect of falling interest rates,” according to the EY ITEM Club.  Mortgage lending to forecast to grow 2.2% in 2024, driven by the Bank of England cutting the base rate to 4% by the end of the year from its current 5.25% as inflation eases,

Families begin to embrace weight-loss drugs for their children - Vimarsana News

Families begin to embrace weight-loss drugs for their children

A small but rapidly growing number of U.S. adolescents began treatment with Novo Nordisk's weight-loss drug Wegovy last year, a powerful new tool to address record rates of pediatric obesity,